Founders and biotech ventures submit their opportunity for review, outlining technology, IP position, and market fit.
Diligence
Our scientific and investment committees conduct technical, regulatory, and commercial due diligence.
Term Sheet
OBH defines the investment framework, milestone-based support, and co-development structure.
Acceleration
Selected ventures gain access to OBH’s labs, GMP pilot suites, regulatory expertise, and strategic partners.
Scale & Integration
Successful ventures expand into GCC markets, integrate with Opal Bio Pharma’s therapeutic pipeline, and position for global partnerships or IPO readiness.
Are you building the future of biotech in the GCC?